The Application of Non-Invasive Apoptosis Detection Sensor (NIADS) on Histone Deacetylation Inhibitor (HDACi)-Induced Breast Cancer Cell Death

The Application of Non-Invasive Apoptosis Detection Sensor (NIADS) on Histone Deacetylation Inhibitor (HDACi)-Induced Breast Cancer Cell Death

Breast cancer is the most common malignancy in women and the second leading cause of cancer death in women. Triple negative breast cancer (TNBC) subtype is a breast cancer subset without ER (estrogen receptor), PR (progesterone receptor) and HER2 (human epidermal growth factor receptor 2) expression...

Full description

Bibliographic Details
Main Authors:	Kai-Wen Hsu, Chien-Yu Huang, Ka-Wai Tam, Chun-Yu Lin, Li-Chi Huang, Ching-Ling Lin, Wen-Shyang Hsieh, Wei-Ming Chi, Yu-Jia Chang, Po-Li Wei, Shou-Tung Chen, Chia-Hwa Lee
Format:	Article
Language:	English
Published:	MDPI AG 2018-02-01
Series:	International Journal of Molecular Sciences
Subjects:	live cell non-invasive apoptosis detection sensor (NIADS) triple negative breast cancer (TNBC) HDACi
Online Access:	http://www.mdpi.com/1422-0067/19/2/452

Similar Items

Lysosome activable polymeric vorinostat encapsulating PD-L1KD for a combination of HDACi and immunotherapy
by: Fengkun Lu, et al.
Published: (2021-01-01)

Low-dose HDACi potentiates anti-tumor activity of macrophages in immunotherapy
by: Xiaolei Li, et al.
Published: (2021-01-01)

Teratoma Growth Retardation by HDACi Treatment of the Tumor Embryonal Source
by: Jure Krasic, et al.
Published: (2020-11-01)

Expression of Adenoviral E1A in Transformed Cells as an Additional Factor of HDACi-Dependent FoxO Regulation
by: Alisa Morshneva, et al.
Published: (2019-12-01)

HDACi mediate UNG2 depletion, dysregulated genomic uracil and altered expression of oncoproteins and tumor suppressors in B- and T-cell lines
by: Tobias S. Iveland, et al.
Published: (2020-04-01)

Role of Histone Deacetylases in Carcinogenesis: Potential Role in Cholangiocarcinoma
by: Kishor Pant, et al.
Published: (2020-03-01)

Efficacy of Azatyrosine-Phenylbutyric Hydroxamides, a Histone Deacetylase Inhibitor, on Chemotherapy-Induced Gastrointestinal Mucositis
by: Po-Lin Liao, et al.
Published: (2019-01-01)

Histone deacetylase inhibitors as potential treatment for spinal muscular atrophy
by: Jafar Mohseni, et al.
Published: (2013-01-01)

ErbB2 Targeted Epigenetic Modulation: Anti-tumor Efficacy of the ADC Trastuzumab-HDACi ST8176AA1
by: Ferdinando Maria Milazzo, et al.
Published: (2020-01-01)

Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities
by: Nikolaos Garmpis, et al.
Published: (2021-03-01)

Selective histone deacetlyase inhibition decreases disease in lupus-prone mice
by: Castaneda, Adrian Lance
Published: (2016)

Subchronic Toxicities of HZ1006, a Hydroxamate-Based Histone Deacetylase Inhibitor, in Beagle Dogs and Sprague-Dawley Rats
by: Xiaofang Zhang, et al.
Published: (2016-11-01)

Early Histone Deacetylase Inhibition Mitigates Ischemia/Reperfusion Brain Injury by Reducing Microglia Activation and Modulating Their Phenotype
by: Shuyuan Li, et al.
Published: (2019-08-01)

Histone Deacetylase Inhibitor-Induced Autophagy in Tumor Cells: Implications for p53
by: Maria Mrakovcic, et al.
Published: (2017-08-01)

Histone Deacetylase Inhibitor Sensitizes ERCC1-High Non-small-Cell Lung Cancer Cells to Cisplatin via Regulating miR-149
by: Yuwen He, et al.
Published: (2020-06-01)

Protein Tyrosine Kinase 7 Regulates EGFR/Akt Signaling Pathway and Correlates With Malignant Progression in Triple-Negative Breast Cancer
by: Nai-Peng Cui, et al.
Published: (2021-07-01)

Design, Synthesis and Cytotoxicity Study of Primary Amides as Histone Deacetylase Inhibitors
by: Duraid Al-Amily, et al.
Published: (2019-12-01)

Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab
by: Luciana Molinero, et al.
Published: (2019-10-01)

Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions
by: Fokhrul Hossain, et al.
Published: (2021-07-01)

Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis
by: Qiang Wu, et al.
Published: (2019-10-01)

Inhibiting Histone Deacetylases in Human Macrophages Promotes Glycolysis, IL-1β, and T Helper Cell Responses to Mycobacterium tuberculosis
by: Donal J. Cox, et al.
Published: (2020-07-01)

Influence of histone deacetylase inhibitors and DNA-methyltransferase inhibitors on the NK cell-mediated lysis of pediatric B-lineage leukemia.
by: Matthias Manuel Pfeiffer, et al.
Published: (2013-04-01)

Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy
by: Bin Tu, et al.
Published: (2020-06-01)

Etude des Histones Désacétylases (HDACs) comme cibles thérapeutiques dans le cancer gastrique
by: Gries, Alexandre
Published: (2018)

PD-L1 expression in triple-negative breast cancer: a cross-sectional study in a Polish population
by: Łukasz Szylberg, et al.
Published: (2021-02-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
by: Dey Nandini, et al.
Published: (2021-05-01)

The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential
by: Kun-Chun Chiang, et al.
Published: (2016-04-01)

The class I-specific HDAC inhibitor MS-275 modulates the differentiation potential of mouse embryonic stem cells
by: Gianluigi Franci, et al.
Published: (2013-08-01)

Histone deacetylase inhibitors induce medulloblastoma cell death independent of HDACs recruited in REST repression complexes
by: Abdulelah S. Alshawli, et al.
Published: (2020-10-01)

Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy
by: Amit Kumar Singh, et al.
Published: (2018-06-01)

Expression of Circular RNA ciRS-7 and Its Effect on Invasion and Migration of Triple-negative Breast Cancer Cells
by: MENG Lingjiao, et al.
Published: (2019-03-01)

Synergistic Effect of Simultaneous versus Sequential Combined Treatment of Histone Deacetylase Inhibitor Valproic Acid with Etoposide on Melanoma Cells
by: Yueh-Ming Shyu, et al.
Published: (2021-09-01)

Clinicopathological Characteristics and Mutational Profiling of Adult T-Cell Lymphoblastic Lymphoma in a Chinese Population
by: Chen F, et al.
Published: (2020-04-01)

Lumpectomy followed by radiation improves survival in HER2 positive and triple‐negative breast cancer with high tumor‐infiltrating lymphocytes compared to mastectomy alone
by: Jason A. Mouabbi, et al.
Published: (2021-07-01)

Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment
by: Dang Tan Nguyen, et al.
Published: (2021-07-01)

Androgen Receptor Expression in Triple-Negative Breast Cancer
by: Samane Jam, et al.
Published: (2019-05-01)

Molecular Investigation on a Triple Negative Breast Cancer Xenograft Model Exposed to Proton Beams
by: Francesco P. Cammarata, et al.
Published: (2020-09-01)

PKCα Modulates Epithelial-to-Mesenchymal Transition and Invasiveness of Breast Cancer Cells Through ZEB1
by: María Candelaria Llorens, et al.
Published: (2019-11-01)

Role of postmastectomy radiotherapy in early-stage (T1–2N0–1M0) triple-negative breast cancer: a systematic review
by: Chen F, et al.
Published: (2017-04-01)